Stock listing
NYSE American:TMBR Timber Pharmaceuticals Inc Stock
Follow Timber Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted AMEX:TMBR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE American:TMBR
- Asset type
- Stock
- Exchange
- NYSE American
- Currency
- USD
Timber Pharmaceuticals Inc on 6ix
- Decks
- 12 decks · latest Jun 29, 2023
Where Timber Pharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:TMBR · This page · Delisted | NYSE American | United States | USD |
| OTC:TMBRQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2023) | Investor deck | 37 slides | Jun 29, 2023 |
| Investor Presentation (February 2023) | Investor deck | 37 slides | Feb 3, 2023 |
| Investor Presentation (September 2022) | Investor deck | 29 slides | Sep 12, 2022 |
| Investor Presentation (June 2022) | Investor deck | 34 slides | Jun 10, 2022 |
| Investor Presentation (December 2021) | Investor deck | 30 slides | Dec 8, 2021 |
| Technical Presentation (November 2021) | Technical | 14 slides | Nov 22, 2021 |
| Investor Presentation (September 2021) | Investor deck | 26 slides | Sep 13, 2021 |
| Investor Presentation (July 2021) | Investor deck | 26 slides | Jul 1, 2021 |
| Investor Presentation (February 2021) | Investor deck | 22 slides | Feb 4, 2021 |
| Corporate Update (December 2020) | Corporate update | 13 slides | Dec 17, 2020 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2020) | Investor deck | 18 slides | Sep 16, 2020 |
| Investor Presentation (May 2020) | Investor deck | 27 slides | May 22, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anja Krammer Other companies: Vivos Therapeutics, Inc. (Director · Since at least Dec 10, 2020) | Director · Jan 21, 2014 – Jan 23, 2019 · Past |
| David E. Cohen Other companies: Evommune, Inc. (Director · Since at least Nov 5, 2025) | Director · Apr 15, 2022 – Apr 15, 2023 · Past |
| Zachary Rome Other companies: PaxMedica, Inc. (Director · Aug 12, 2022 – Mar 12, 2024 · Past) | Director · May 18, 2020 – Mar 4, 2022 · Past |
| Alan Mendelsohn | EVP & CMO · Feb 4, 2021 – Aug 20, 2023 · Past |
| Amir Tavakkol | Chief Scientific Officer · May 18, 2020 – May 18, 2020 · Past |
| John Koconis | CEO & Chairman · May 18, 2020 – Aug 20, 2023 · Past |
| Joseph Lucchese | EVP & CFO · May 18, 2020 – Aug 20, 2023 · Past |
| Kin Foong Chan | EVP of R&D · Jun 12, 2019 – Jun 12, 2019 · Past |
| Linda A Broenniman | Director · May 18, 2020 – Jun 8, 2020 · Past |
| Lubor Gaal | Director · Aug 19, 2020 – Apr 15, 2023 · Past |
All 11 people
| Person | Seat |
|---|---|
| Michael Stocum | Director · May 18, 2020 – Jun 8, 2020 · Past |
Log in to ask 6ix AI your own questions about Timber Pharmaceuticals Inc.